ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cytomegalovirus (CMV) Vaccine Market Insights, Forecast to 2030
Published Date: September 2024
|
Report Code: QYRE-Auto-19O10054
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Cytomegalovirus CMV Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Cytomegalovirus (CMV) Vaccine Market Insights, Forecast to 2030

Code: QYRE-Auto-19O10054
Report
September 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
AlphaVax
Moderna, Inc
Novartis

Cytomegalovirus (CMV) Vaccine Market Size

The global Cytomegalovirus (CMV) Vaccine market is projected to grow from US$ 159 million in 2024 to US$ 205.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.

Cytomegalovirus (CMV) Vaccine Market

Cytomegalovirus (CMV) Vaccine Market

Cytomegalovirus (CMV) also known as HCMV, or Human Herpesvirus 5 (HHV-5) is the virus most commonly transmitted to a developing fetus. It is a common virus that infects people of all ages. According to the CDC, over half of adults by age 40 have been infected with CMV. Most people infected with CMV show no signs or symptoms. Whereas when a baby is born with cytomegalovirus (CMV) infection, it is called congenital CMV. Each year, approximately 5,000 infants in the U.S. may develop permanent problems due to CMV, some of the severe problems, includes deafness, blindness, and mental retardation. Furthermore, the global prevalence of congenital cytomegalovirus is said to be 0.3 – 2.0%. The Institute of Medicine (IOM) of the National Academy of Sciences, has designated CMV as a “highest priority” category for vaccine development, citing the years of life and disability that could be saved.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Cytomegalovirus (CMV) Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cytomegalovirus (CMV) Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Cytomegalovirus (CMV) Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cytomegalovirus (CMV) Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Cytomegalovirus (CMV) Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Cytomegalovirus (CMV) Vaccine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Cytomegalovirus (CMV) Vaccine Market Report

Report Metric Details
Report Name Cytomegalovirus (CMV) Vaccine Market
Accounted market size in 2024 US$ 159 million
Forecasted market size in 2030 US$ 205.9 million
CAGR 4.4
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Attenuated Vaccines
  • Subunit Vaccines
Segment by Application
  • Laboratories
  • Hospitals
  • Diagnostic Centers and Clinics
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Moderna, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Cytomegalovirus (CMV) Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Cytomegalovirus (CMV) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytomegalovirus (CMV) Vaccine sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Cytomegalovirus (CMV) Vaccine Market growing?

Ans: The Cytomegalovirus (CMV) Vaccine Market witnessing a CAGR of 4.4 during the forecast period 2024-2030.

What is the Cytomegalovirus (CMV) Vaccine Market size in 2030?

Ans: The Cytomegalovirus (CMV) Vaccine Market size in 2030 will be US$ 205.9 million.

Who are the main players in the Cytomegalovirus (CMV) Vaccine Market report?

Ans: The main players in the Cytomegalovirus (CMV) Vaccine Market are Moderna, Novartis

What are the Application segmentation covered in the Cytomegalovirus (CMV) Vaccine Market report?

Ans: The Applications covered in the Cytomegalovirus (CMV) Vaccine Market report are Laboratories, Hospitals, Diagnostic Centers and Clinics, Others

What are the Type segmentation covered in the Cytomegalovirus (CMV) Vaccine Market report?

Ans: The Types covered in the Cytomegalovirus (CMV) Vaccine Market report are Attenuated Vaccines, Subunit Vaccines

1 Study Coverage
1.1 Cytomegalovirus (CMV) Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Cytomegalovirus (CMV) Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Attenuated Vaccines
1.2.3 Subunit Vaccines
1.3 Market by Application
1.3.1 Global Cytomegalovirus (CMV) Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Diagnostic Centers and Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cytomegalovirus (CMV) Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Region
2.2.1 Global Cytomegalovirus (CMV) Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Region (2019-2024)
2.2.3 Global Cytomegalovirus (CMV) Vaccine Revenue by Region (2025-2030)
2.2.4 Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Region (2019-2030)
2.3 Global Cytomegalovirus (CMV) Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global Cytomegalovirus (CMV) Vaccine Sales by Region
2.4.1 Global Cytomegalovirus (CMV) Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Cytomegalovirus (CMV) Vaccine Sales by Region (2019-2024)
2.4.3 Global Cytomegalovirus (CMV) Vaccine Sales by Region (2025-2030)
2.4.4 Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Cytomegalovirus (CMV) Vaccine Sales by Manufacturers
3.1.1 Global Cytomegalovirus (CMV) Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cytomegalovirus (CMV) Vaccine in 2023
3.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Manufacturers
3.2.1 Global Cytomegalovirus (CMV) Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Cytomegalovirus (CMV) Vaccine Revenue in 2023
3.3 Global Key Players of Cytomegalovirus (CMV) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Cytomegalovirus (CMV) Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cytomegalovirus (CMV) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cytomegalovirus (CMV) Vaccine Sales by Type
4.1.1 Global Cytomegalovirus (CMV) Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global Cytomegalovirus (CMV) Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Type
4.2.1 Global Cytomegalovirus (CMV) Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global Cytomegalovirus (CMV) Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Cytomegalovirus (CMV) Vaccine Price by Type
4.3.1 Global Cytomegalovirus (CMV) Vaccine Price by Type (2019-2024)
4.3.2 Global Cytomegalovirus (CMV) Vaccine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Cytomegalovirus (CMV) Vaccine Sales by Application
5.1.1 Global Cytomegalovirus (CMV) Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global Cytomegalovirus (CMV) Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Application
5.2.1 Global Cytomegalovirus (CMV) Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global Cytomegalovirus (CMV) Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Cytomegalovirus (CMV) Vaccine Price by Application
5.3.1 Global Cytomegalovirus (CMV) Vaccine Price by Application (2019-2024)
5.3.2 Global Cytomegalovirus (CMV) Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Cytomegalovirus (CMV) Vaccine Market Size by Type
6.1.1 US & Canada Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2030)
6.2 US & Canada Cytomegalovirus (CMV) Vaccine Market Size by Application
6.2.1 US & Canada Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2030)
6.3 US & Canada Cytomegalovirus (CMV) Vaccine Market Size by Country
6.3.1 US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Cytomegalovirus (CMV) Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Cytomegalovirus (CMV) Vaccine Market Size by Type
7.1.1 Europe Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2030)
7.1.2 Europe Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2030)
7.2 Europe Cytomegalovirus (CMV) Vaccine Market Size by Application
7.2.1 Europe Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2030)
7.2.2 Europe Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2030)
7.3 Europe Cytomegalovirus (CMV) Vaccine Market Size by Country
7.3.1 Europe Cytomegalovirus (CMV) Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Cytomegalovirus (CMV) Vaccine Sales by Country (2019-2030)
7.3.3 Europe Cytomegalovirus (CMV) Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Cytomegalovirus (CMV) Vaccine Market Size
8.1.1 China Cytomegalovirus (CMV) Vaccine Sales (2019-2030)
8.1.2 China Cytomegalovirus (CMV) Vaccine Revenue (2019-2030)
8.2 China Cytomegalovirus (CMV) Vaccine Market Size by Application
8.2.1 China Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2030)
8.2.2 China Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cytomegalovirus (CMV) Vaccine Market Size by Type
9.1.1 Asia Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2030)
9.1.2 Asia Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2030)
9.2 Asia Cytomegalovirus (CMV) Vaccine Market Size by Application
9.2.1 Asia Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2030)
9.2.2 Asia Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2030)
9.3 Asia Cytomegalovirus (CMV) Vaccine Sales by Region
9.3.1 Asia Cytomegalovirus (CMV) Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Cytomegalovirus (CMV) Vaccine Revenue by Region (2019-2030)
9.3.3 Asia Cytomegalovirus (CMV) Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Cytomegalovirus (CMV) Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Cytomegalovirus (CMV) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 AlphaVax
11.2.1 AlphaVax Company Information
11.2.2 AlphaVax Overview
11.2.3 AlphaVax Cytomegalovirus (CMV) Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 AlphaVax Cytomegalovirus (CMV) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AlphaVax Recent Developments
11.3 Moderna
11.3.1 Moderna Company Information
11.3.2 Moderna Overview
11.3.3 Moderna Cytomegalovirus (CMV) Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Moderna Cytomegalovirus (CMV) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Moderna Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Cytomegalovirus (CMV) Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novartis Cytomegalovirus (CMV) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cytomegalovirus (CMV) Vaccine Industry Chain Analysis
12.2 Cytomegalovirus (CMV) Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cytomegalovirus (CMV) Vaccine Production Mode & Process
12.4 Cytomegalovirus (CMV) Vaccine Sales and Marketing
12.4.1 Cytomegalovirus (CMV) Vaccine Sales Channels
12.4.2 Cytomegalovirus (CMV) Vaccine Distributors
12.5 Cytomegalovirus (CMV) Vaccine Customers
13 Market Dynamics
13.1 Cytomegalovirus (CMV) Vaccine Industry Trends
13.2 Cytomegalovirus (CMV) Vaccine Market Drivers
13.3 Cytomegalovirus (CMV) Vaccine Market Challenges
13.4 Cytomegalovirus (CMV) Vaccine Market Restraints
14 Key Findings in The Global Cytomegalovirus (CMV) Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Merck
AlphaVax
Moderna, Inc
Novartis
List of Tables
    Table 1. Global Cytomegalovirus (CMV) Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Attenuated Vaccines
    Table 3. Major Manufacturers of Subunit Vaccines
    Table 4. Global Cytomegalovirus (CMV) Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Cytomegalovirus (CMV) Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Cytomegalovirus (CMV) Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Cytomegalovirus (CMV) Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Region (2019-2024)
    Table 9. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Region (2025-2030)
    Table 10. Global Cytomegalovirus (CMV) Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Cytomegalovirus (CMV) Vaccine Sales by Region (2019-2024) & (K Doses)
    Table 12. Global Cytomegalovirus (CMV) Vaccine Sales by Region (2025-2030) & (K Doses)
    Table 13. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Region (2019-2024)
    Table 14. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Region (2025-2030)
    Table 15. Global Cytomegalovirus (CMV) Vaccine Sales by Manufacturers (2019-2024) & (K Doses)
    Table 16. Global Cytomegalovirus (CMV) Vaccine Sales Share by Manufacturers (2019-2024)
    Table 17. Global Cytomegalovirus (CMV) Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Cytomegalovirus (CMV) Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Cytomegalovirus (CMV) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Cytomegalovirus (CMV) Vaccine Price by Manufacturers 2019-2024 (US$/Dose)
    Table 21. Global Cytomegalovirus (CMV) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Cytomegalovirus (CMV) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (CMV) Vaccine as of 2023)
    Table 23. Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Product Offered and Application
    Table 25. Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 28. Global Cytomegalovirus (CMV) Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 29. Global Cytomegalovirus (CMV) Vaccine Sales Share by Type (2019-2024)
    Table 30. Global Cytomegalovirus (CMV) Vaccine Sales Share by Type (2025-2030)
    Table 31. Global Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Cytomegalovirus (CMV) Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Cytomegalovirus (CMV) Vaccine Revenue Share by Type (2019-2024)
    Table 34. Global Cytomegalovirus (CMV) Vaccine Revenue Share by Type (2025-2030)
    Table 35. Cytomegalovirus (CMV) Vaccine Price by Type (2019-2024) & (US$/Dose)
    Table 36. Global Cytomegalovirus (CMV) Vaccine Price Forecast by Type (2025-2030) & (US$/Dose)
    Table 37. Global Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 38. Global Cytomegalovirus (CMV) Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 39. Global Cytomegalovirus (CMV) Vaccine Sales Share by Application (2019-2024)
    Table 40. Global Cytomegalovirus (CMV) Vaccine Sales Share by Application (2025-2030)
    Table 41. Global Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Cytomegalovirus (CMV) Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Cytomegalovirus (CMV) Vaccine Revenue Share by Application (2019-2024)
    Table 44. Global Cytomegalovirus (CMV) Vaccine Revenue Share by Application (2025-2030)
    Table 45. Cytomegalovirus (CMV) Vaccine Price by Application (2019-2024) & (US$/Dose)
    Table 46. Global Cytomegalovirus (CMV) Vaccine Price Forecast by Application (2025-2030) & (US$/Dose)
    Table 47. US & Canada Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 48. US & Canada Cytomegalovirus (CMV) Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 49. US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 52. US & Canada Cytomegalovirus (CMV) Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 53. US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Cytomegalovirus (CMV) Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Cytomegalovirus (CMV) Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Cytomegalovirus (CMV) Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 59. US & Canada Cytomegalovirus (CMV) Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 60. Europe Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 61. Europe Cytomegalovirus (CMV) Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 62. Europe Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Cytomegalovirus (CMV) Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 65. Europe Cytomegalovirus (CMV) Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 66. Europe Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Cytomegalovirus (CMV) Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Cytomegalovirus (CMV) Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Cytomegalovirus (CMV) Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Cytomegalovirus (CMV) Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Cytomegalovirus (CMV) Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 72. Europe Cytomegalovirus (CMV) Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 73. China Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 74. China Cytomegalovirus (CMV) Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 75. China Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Cytomegalovirus (CMV) Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 78. China Cytomegalovirus (CMV) Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 79. China Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Cytomegalovirus (CMV) Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 82. Asia Cytomegalovirus (CMV) Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 83. Asia Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Cytomegalovirus (CMV) Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 86. Asia Cytomegalovirus (CMV) Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 87. Asia Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Cytomegalovirus (CMV) Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Cytomegalovirus (CMV) Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Cytomegalovirus (CMV) Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Cytomegalovirus (CMV) Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Cytomegalovirus (CMV) Vaccine Sales by Region (2019-2024) & (K Doses)
    Table 93. Asia Cytomegalovirus (CMV) Vaccine Sales by Region (2025-2030) & (K Doses)
    Table 94. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Type (2019-2024) & (K Doses)
    Table 95. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Type (2025-2030) & (K Doses)
    Table 96. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Application (2019-2024) & (K Doses)
    Table 99. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Application (2025-2030) & (K Doses)
    Table 100. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Country (2019-2024) & (K Doses)
    Table 106. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales by Country (2025-2030) & (K Doses)
    Table 107. Merck Company Information
    Table 108. Merck Description and Major Businesses
    Table 109. Merck Cytomegalovirus (CMV) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 110. Merck Cytomegalovirus (CMV) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Merck Recent Developments
    Table 112. AlphaVax Company Information
    Table 113. AlphaVax Description and Major Businesses
    Table 114. AlphaVax Cytomegalovirus (CMV) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 115. AlphaVax Cytomegalovirus (CMV) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. AlphaVax Recent Developments
    Table 117. Moderna Company Information
    Table 118. Moderna Description and Major Businesses
    Table 119. Moderna Cytomegalovirus (CMV) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 120. Moderna Cytomegalovirus (CMV) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Moderna Recent Developments
    Table 122. Novartis Company Information
    Table 123. Novartis Description and Major Businesses
    Table 124. Novartis Cytomegalovirus (CMV) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 125. Novartis Cytomegalovirus (CMV) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Novartis Recent Developments
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Cytomegalovirus (CMV) Vaccine Distributors List
    Table 130. Cytomegalovirus (CMV) Vaccine Customers List
    Table 131. Cytomegalovirus (CMV) Vaccine Market Trends
    Table 132. Cytomegalovirus (CMV) Vaccine Market Drivers
    Table 133. Cytomegalovirus (CMV) Vaccine Market Challenges
    Table 134. Cytomegalovirus (CMV) Vaccine Market Restraints
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cytomegalovirus (CMV) Vaccine Product Picture
    Figure 2. Global Cytomegalovirus (CMV) Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cytomegalovirus (CMV) Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Attenuated Vaccines Product Picture
    Figure 5. Subunit Vaccines Product Picture
    Figure 6. Global Cytomegalovirus (CMV) Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Cytomegalovirus (CMV) Vaccine Market Share by Application in 2023 & 2030
    Figure 8. Laboratories
    Figure 9. Hospitals
    Figure 10. Diagnostic Centers and Clinics
    Figure 11. Others
    Figure 12. Cytomegalovirus (CMV) Vaccine Report Years Considered
    Figure 13. Global Cytomegalovirus (CMV) Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Cytomegalovirus (CMV) Vaccine Revenue 2019-2030 (US$ Million)
    Figure 15. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Region (2019-2030)
    Figure 17. Global Cytomegalovirus (CMV) Vaccine Sales 2019-2030 ((K Doses)
    Figure 18. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Cytomegalovirus (CMV) Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 20. US & Canada Cytomegalovirus (CMV) Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Cytomegalovirus (CMV) Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 22. Europe Cytomegalovirus (CMV) Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Cytomegalovirus (CMV) Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 24. China Cytomegalovirus (CMV) Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Cytomegalovirus (CMV) Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 26. Asia (excluding China) Cytomegalovirus (CMV) Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales YoY (2019-2030) & (K Doses)
    Figure 28. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Cytomegalovirus (CMV) Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Cytomegalovirus (CMV) Vaccine in the World: Market Share by Cytomegalovirus (CMV) Vaccine Revenue in 2023
    Figure 31. Global Cytomegalovirus (CMV) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2019-2030)
    Figure 33. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2019-2030)
    Figure 34. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2019-2030)
    Figure 35. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Cytomegalovirus (CMV) Vaccine Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Cytomegalovirus (CMV) Vaccine Sales Share by Country (2019-2030)
    Figure 42. U.S. Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2019-2030)
    Figure 45. Europe Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2019-2030)
    Figure 47. Europe Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Cytomegalovirus (CMV) Vaccine Revenue Share by Country (2019-2030)
    Figure 49. Europe Cytomegalovirus (CMV) Vaccine Sales Share by Country (2019-2030)
    Figure 50. Germany Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 51. France Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 55. China Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2019-2030)
    Figure 56. China Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2019-2030)
    Figure 57. China Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2019-2030)
    Figure 58. China Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2019-2030)
    Figure 60. Asia Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2019-2030)
    Figure 62. Asia Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Cytomegalovirus (CMV) Vaccine Revenue Share by Region (2019-2030)
    Figure 64. Asia Cytomegalovirus (CMV) Vaccine Sales Share by Region (2019-2030)
    Figure 65. Japan Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 69. India Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Cytomegalovirus (CMV) Vaccine Sales Share by Country (2019-2030)
    Figure 76. Brazil Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Cytomegalovirus (CMV) Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 81. Cytomegalovirus (CMV) Vaccine Value Chain
    Figure 82. Cytomegalovirus (CMV) Vaccine Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Measles Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-34D11827
Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Vaccine Delivery Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35Z7701
Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Pediatric Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Brucella Melitensis Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-27A12787
Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions